0000950170-23-046760.txt : 20230906 0000950170-23-046760.hdr.sgml : 20230906 20230906164030 ACCESSION NUMBER: 0000950170-23-046760 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230902 FILED AS OF DATE: 20230906 DATE AS OF CHANGE: 20230906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ganot Ilan CENTRAL INDEX KEY: 0001727460 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38360 FILM NUMBER: 231239738 MAIL ADDRESS: STREET 1: C/O SOLID BIOSCIENCES, LLC STREET 2: 141 PORTLAND STREET, FIFTH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Solid Biosciences Inc. CENTRAL INDEX KEY: 0001707502 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 900943402 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 RUTHERFORD AVENUE STREET 2: 3RD FLOOR CITY: CHARLESTOWN STATE: MA ZIP: 02129 BUSINESS PHONE: 617-337-4680 MAIL ADDRESS: STREET 1: 500 RUTHERFORD AVENUE STREET 2: 3RD FLOOR CITY: CHARLESTOWN STATE: MA ZIP: 02129 FORMER COMPANY: FORMER CONFORMED NAME: Solid Biosciences, LLC DATE OF NAME CHANGE: 20170524 4 1 ownership.xml 4 X0508 4 2023-09-02 false 0001707502 Solid Biosciences Inc. SLDB 0001727460 Ganot Ilan C/O SOLID BIOSCIENCES 500 RUTHERFORD AVENUE CHARLESTOWN MA 02129 true false false false false Common Stock 2023-09-02 4 M false 1583 A 89341 D Common Stock 19394 I See Footnote Common Stock 4323 I Wife Restricted Stock Units 2023-09-02 4 M false 1583 0.00 D Common Stock 1583 1583 D Restricted stock units convert into common stock on a one-for-one basis. Represents 85,299 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship. Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017. Includes 1,879 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2023. On December 2, 2022 (the "Grant Date"), Mr. Ganot was granted 6,333 restricted stock units, vesting in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of a change in control the restricted stock units shall accelerate in full. /s/ David Tyronne Howton as attorney-in-fact for Ilan Ganot 2023-09-06